We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+21.54%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.08B
AUM Growth
+$375M
Cap. Flow
-$205M
Cap. Flow %
-3.37%
Top 10 Hldgs %
23.61%
Holding
263
New
25
Increased
137
Reduced
69
Closed
23

Top Buys

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$34.7M
2
TLN
Talen Energy Corp
TLN
+$29.8M
3
ABVX
Abivax
ABVX
+$24.3M
4
EVH icon
Evolent Health
EVH
+$21.4M
5
PLD icon
Prologis
PLD
+$16.2M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$212M
2
BPMC
Blueprint Medicines
BPMC
+$93.4M
3
WDAY icon
Workday
WDAY
+$28M
4
RELY icon
Remitly
RELY
+$27M
5
INSM icon
Insmed
INSM
+$23.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.53%
2 Industrials 18.58%
3 Technology 17.54%
4 Consumer Discretionary 8.04%
5 Utilities 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETR icon
26
Entergy
ETR
$49.3B
$60.7M 1%
651,043
+57,946
+10% +$5.1M
MTD icon
27
Mettler-Toledo International
MTD
$28B
$60.6M 1%
49,443
+890
+2% +$1.12M
NDAQ icon
28
Nasdaq
NDAQ
$55.5B
$59.7M 0.98%
674,642
+129,741
+24% +$12M
ORLY icon
29
O'Reilly Automotive
ORLY
$71.6B
$57.5M 0.94%
533,086
+4,750
+0.9% +$477K
LAD icon
30
Lithia Motors
LAD
$8.14B
$57.3M 0.94%
181,175
-4,011
-2% -$1.29M
RBA icon
31
RB Global
RBA
$15.9B
$57M 0.94%
526,319
+2,187
+0.4% +$245K
CHWY icon
32
Chewy
CHWY
$9.52B
$57M 0.94%
1,409,144
+343,572
+32% +$13.2M
WCN
33
Waste Connections
WCN
$41.7B
$54.4M 0.89%
309,521
+353
+0.1% +$64.2K
CELC icon
34
Celcuity
CELC
$4.33B
$53.8M 0.88%
1,088,799
-300,628
-22% -$12M
NVT icon
35
nVent Electric
NVT
$24B
$53.3M 0.88%
541,333
+10,110
+2% +$878K
EVH icon
36
Evolent Health
EVH
$520M
$53.2M 0.88%
6,292,511
+2,205,659
+54% +$21.4M
VMC icon
37
Vulcan Materials
VMC
$35.6B
$51.7M 0.85%
167,954
-28
-0% -$7.95K
KLAC icon
38
KLA
KLAC
$229B
$50.1M 0.82%
465,490
+69,300
+17% +$6.47M
DDOG icon
39
Datadog
DDOG
$85.1B
$50M 0.82%
350,794
+1,644
+0.5% +$226K
AXON
40
Axon Enterprise
AXON
$48.8B
$49.6M 0.82%
69,104
+1,783
+3% +$1.35M
CLDX icon
41
Celldex Therapeutics
CLDX
$3.07B
$48.1M 0.79%
1,859,095
+502,909
+37% +$11.7M
TLN
42
Talen Energy Corp
TLN
$14.2B
$47.5M 0.78%
111,759
+82,524
+282% +$29.8M
SITM icon
43
SiTime
SITM
$16.8B
$46.9M 0.77%
155,608
+1,312
+0.9% +$304K
ALNY icon
44
Alnylam Pharmaceuticals
ALNY
$31.7B
$46.4M 0.76%
101,739
-24,163
-19% -$9.84M
VRSK icon
45
Verisk Analytics
VRSK
$25B
$45.8M 0.75%
182,010
+10,878
+6% +$2.99M
NTNX icon
46
Nutanix
NTNX
$18.7B
$45.5M 0.75%
610,963
-21,772
-3% -$1.6M
HLI icon
47
Houlihan Lokey
HLI
$9.3B
$45.2M 0.74%
220,048
+24,954
+13% +$4.89M
LSCC icon
48
Lattice Semiconductor
LSCC
$16.2B
$44.7M 0.74%
610,088
+18,355
+3% +$1.12M
NVDA icon
49
NVIDIA
NVDA
$5.25T
$44.2M 0.73%
238,539
-9,072
-4% -$1.58M
PNR icon
50
Pentair
PNR
$9.84B
$43.9M 0.72%
396,769
+12,307
+3% +$1.31M
1
2
3 4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, Eventide Asset Management held 263 positions worth $6.08B, up 6.6% from $5.71B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management withdrew a net $205M in Q3 2025, closing 23 positions and reducing 69 holdings. Its most notable exit was Blueprint Medicines, an estimated $93.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in Soleno Therapeutics worth $31.6M.

  • Eventide Asset Management's largest Q3 2025 buy was Soleno Therapeutics: 467,435 shares worth $31.6M.
  • Eventide Asset Management added most to Talen Energy Corp in Q3 2025, an estimated $29.8M increase.
  • Eventide Asset Management's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $212M.
  • Eventide Asset Management fully exited Blueprint Medicines in Q3 2025, selling an estimated $93.4M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.08B portfolio in Q3 2025.
  • Eventide Asset Management opened 25 new positions and closed 23 in Q3 2025.
  • Eventide Asset Management's portfolio value rose 6.6% quarter-over-quarter to $6.08B.

Based on Eventide Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.